by Katie Nightingale | Apr 18, 2023 | Myrovlytis Trust Blog
The British Sarcoma Group (BSG) annual conference took place on March 22nd – 23rd 2023 in Newport, Wales. We were delighted to attend as an exhibitor to promote our Osteosarcoma Now Trial Explorer (ONTEX) and our 2023 grant funding round. It was also inspiring to hear...
by Katie Nightingale | Jan 31, 2023 | Myrovlytis Trust Blog
We are delighted to announce the first group of our 2022 grant holders. After re-establishing the Trust’s grant giving activity in 2021, we were keen to build upon that success and expand our research portfolio. In 2022, we focused on 1 year projects and PhD...
by Katie Nightingale | Nov 24, 2022 | Myrovlytis Trust Blog
The first BHD Community Symposium was held on October 8th, 2022. We were delighted to have over 200 people registered from 22 countries across 5 continents for this virtual event. This year’s symposium was the first deliberately designed to be accessible to all...
by Katie Nightingale | Oct 19, 2022 | Myrovlytis Trust Blog
In September 2022, we attended the Immuno UK conference. Held over 2 days in London, UK, this conference brought together over 260 people from industry and academic research. We heard the latest updates in the field of “immune oncology”. This can be described as...
by Katie Nightingale | Oct 10, 2022 | Uncategorized
On 22nd November 2022, a mini-symposium “On Birt-Hogg-Dubé Syndrome and Folliculin” is being held in celebration of the PhD defenses of Irma van de Beek and Iris Glykofridis. The event will feature an update about the current and future BHD research taking place at...
Recent Comments